Medical treatment of gallstone disease

Biliary Lithiasis: Basic Science, Current Diagnosis and Management

Volumn , Issue , 2008, Pages 149-157

  Portincasa, Piero ^a   Moschetta, Antonio ^a,b   Puglisi, Francesco ^a   Borracino, Luigi ^a   Wang, David Q H ^c  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b Consorzio Mario Negri Sud ^*  (Italy)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952797973     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-88-470-0763-5_13     Document Type: Chapter

References (85)

1. Portincasa P, Moschetta A, Palasciano G (2006) Cholesterol gallstone disease. Lancet 368:230-239
2. Portincasa P, Moschetta A, Petruzzelli M et al (2006) Gallstone disease: symptoms and diagnosis of gallbladder stones. Best Pract Res Clin Gastroenterol 20:1017-1029
3. Diehl AK, Sugarek NJ, Todd KH (1990) Clinical evaluation for gallstone disease: usefulness of symptoms and signs in diagnosis. Am J Med 89:29-33
4. Paumgartner G, Carr-Locke DL, Roda E et al (1988) Biliary stones: non-surgical therapeutic approach. Gastroenterology International 1:17-24
5. Jorgensen T (1989) Abdominal symptoms and gallstone disease: an epidemiological investigation. Hepatology 9:856-860
6. Berhane T, Vetrhus M, Hausken T et al (2006) Pain attacks in non-complicated and complicated gallstone disease have a characteristic pattern and are accompanied by dyspepsia in most patients: the results of a prospective study. Scand J Gastroenterol 41:93-101
7. Friedman GD, Raviola CA, Fireman B (1989) Prognosis of gallstones with mild or no symptoms: 25 years of follow-up in a health maintenance organization. J Clin Epidemiol 42:127-136
8. Gibney EJ (1990) Asymptomatic gallstones. Br J Surg 77:368-372
9. Festi D, Sottili S, Colecchia A et al (1999) Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL). Hepatology 30:839-846
10. Thistle JL, Cleary PA, Lachin JM et al (1984) The natural history of cholelithiasis: the National Cooperative Gallstone Study. Ann Intern Med 101:171-175
11. Venneman NG, Renooij W, Rehfeld JF et al (2005) Small gallstones, preserved gallbladder motility, and fast crystallization are associated with pancreatitis. Hepatology 41:738-746
12. Venneman NG, Buskens E, Besselink MG et al (2005) Small gallstones are associated with increased risk of acute pancreatitis: potential benefits of prophylactic cholecystectomy? Am J Gastroenterol 100:2540-2550
13. Paumgartner G, Carr-Locke DL, Dubois F et al (1993) Strategies in the treatment of gallstone disease. Working team report. Gastroenterology International 6:65-75
14. Brugge WR (2000) The silent gallstone. In: gallbladder and biliary tract diseases. Afdhal NH (ed) New York, Basel, Marcel Dekker, Inc., pp 447-453
15. Tait N, Little JM (1995) The treatment of gall stones. BMJ 311:99-105
16. Hofmann AF, Amelsberg A, Vansonnenberg E (1993) Pathogenesis and treatment of gallstones. N Engl J Med 328:1854-1855
17. Johnston DE, Kaplan MM (1993) Pathogenesis and treatment of gallstones. N Engl J Med 328:412-421
18. Pokorny WJ, Saleem M, O'Gorman RB et al (1984) Cholelithiasis and cholecystitis in childhood. Am J Surg 148:742-744
19. Amaral JF, Thompson WR (1985) Gallbladder disease in the morbidly obese. Am J Surg 149:551-557
20. Sleisenger MH, Fordtran JS (2006) Gastrointestinal disease: pathophysiology, diagnosis, management, 8th edn. Philadelphia, W. B. Saunders
21. Lowenfels AB, Walker AM, Althaus DP et al (1989) Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int J Epidemiol 18:50-54
22. Randi G, Franceschi S, La VC (2006) Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 118:1591-1602
23. Ashur H, Siegal B, Oland Y et al (1978) Calcified ballbladder (porcelain gallbladder). Arch Surg 113:594-596
24. Lowenfels AB, Lindstrom CG, Conway MJ et al (1985) Gallstones and risk of gallbladder cancer. J Natl Cancer Inst 75:77-80
25. Bonatsos G, Birbas K, Toutouzas K et al (2001) Laparoscopic cholecystectomy in adults with sickle cell disease. Surg Endosc 15:816-819
26. Graham SM, Flowers JL, Schweitzer E et al (1995) Opportunistic upper gastrointestinal infection in transplant recipients. Surg Endosc 9:146-150
27. Graham SM, Flowers JL, Schweitzer E et al (1995) The utility of prophylactic laparoscopic cholecystectomy in transplant candidates. Am J Surg 169:44-48
28. Kao LS, Kuhr CS, Flum DR (2003) Should cholecystectomy be performed for asymptomatic cholelithiasis in transplant patients? J Am Coll Surg 197:302-312
29. Shiffman ML, Sugerman HJ, Kellum JH et al (1993) Gallstones in patients with morbid obesity. Relationship to body weight, weight loss and gallbladder bile cholesterol solubility. Int J Obes 17:153-158
30. Shiffman ML, Sugerman HJ, Kellum JM et al (1991) Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 86:1000-1005
31. Liem RK, Niloff PH (2004) Prophylactic cholecystectomy with open gastric bypass operation. Obes Surg 14:763-765
32. Lee SP, Nicholls JF, Park HZ (1992) Biliary sludge as a cause of acute pancreatitis. N Engl J Med 326:589-593
33. Ros E, Navarro S, Bru C et al (1991) Occult microlithiasis in 'idiopathic' acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy [see comments]. Gastroenterology 101:1701-1709
34. National Institutes of Health Consensus Development Conference Statement on Gallstones and Laparoscopic Cholecystectomy. Am J Surg 165:390-398
35. Schoenfield LJ, Carulli N, Dowling RH et al (1989) Asymptomatic gallstones: definition and treatment. Gastroenterology International 2:25-29
36. Sauerbruch T, Paumgartner G (1991) Gallbladder stones: management. Lancet 338:1121-1124
37. Kumar A, Deed JS, Bhasin B et al (2004) Comparison of the effect of diclofenac with hyoscine-Nbutylbromide in the symptomatic treatment of acute biliary colic. ANZ J Surg 74:573-576
38. Al-Waili N, Saloom KY (1998) The analgesic effect of intravenous tenoxicam in symptomatic treatment of biliary colic: a comparison with hyoscine N-butylbromide. Eur J Med Res 3:475-479
39. Akriviadis EA, Hatzigavriel M, Kapnias D et al (1997) Treatment of biliary colic with diclofenac: a randomized, double-blind, placebo-controlled study. Gastroenterology 113:225-231
40. Goldman G, Kahn PJ, Alon R et al (1989) Biliary colic treatment and acute cholecystitis prevention by prostaglandin inhibitor. Dig Dis Sci 34:809-811
41. Gracie WA, Ransohoff DF (1982) The natural history of silent gallstones: the "innocent" gallstone" is not a myth. N Engl J Med 307:798-800
42. Friedman GD (1993) Natural history of asymptomatic and symptomatic gallstones. Am J Surg 165:399-404
43. Tint GS, Salen G, Colalillo A et al (1982) Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones. Ann Intern Med 97:351-356
44. Meredith TJ, Williams GV, Maton PN et al (1982) Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones. Gut 23:382-389
45. Tomida S, Abei M, Yamaguchi T et al (1999) Longterm ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis. Hepatology 30:6-13
46. Venneman NG, Besselink MG, Keulemans YC et al (2006) Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy. Hepatology 43:1276-1283
47. Sauerbruch T, Delius M, Paumgartner G et al (1986) Fragmentation of gallstones by extracorporeal shock waves. N Engl J Med 314:818-822
48. Allen MJ, Borody TJ, Bugliosi TF et al (1985) Rapid dissolution of gallstones by methyl tert-butyl ether. Preliminary observations. N Engl J Med 312:217-220
49. Hellstern A, Leuschner U, Benjaminov A et al (1998) Dissolution of gallbladder stones with methyl tert-butyl ether and stone recurrence: a European survey. Dig Dis Sci 43:911-920
50. Paumgartner G, Sauter GH (2005) Extracorporeal shock wave lithotripsy of gallstones: 20th anniversary of the first treatment. Eur J Gastroenterol Hepatol 17:525-527
51. Nunes DP (2007) Nonsurgical treatment of gallstone disease. UpToDate 1-5
52. Paumgartner G, Pauletzki J, Sackmann M (1994) Ursodeoxycholic acid treatment of cholesterol gallstone disease. Scand J Gastroenterol Suppl 204:27-31
53. Leopold GR, Amberg J, Gosink BB et al (1976) Gray scale ultrasonic cholecystography: a comparison with conventional radiographic techniques. Radiology 121:445-448
54. Portincasa P, Di Ciaula A, Palmieri VO et al (1994) Sonographic evaluation of gallstone burden in humans. Ital J Gastroenterol Hepatol 26:141-144
55. Everson GT, Braverman DZ, Johnson ML et al (1980) A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology 79:40-46
56. Portincasa P, Moschetta A, Colecchia A et al (2003) Measurement of gallbladder motor function by ultrasonography: towards for standardization. Dig Liver Dis (già Ital J Gastroenterol Hepatol) 35(Suppl 3):S56-S61
57. Pauletzki JG, Althaus R, Holl J et al (1996) Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence. Gastroenterology 111:765-771
58. Portincasa P, van Erpecum KJ, van de Meeberg PC et al (1996) Apolipoprotein (Apo) E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after ex-tracorporeal shock-wave lithotripsy. Hepatology 24:580-587
59. Venneman NG, van Berge-Henegouwen GP, Portincasa P et al (2001) Absence of apolipoprotein E4 genotype, good gallbladder motility and presence of solitary stones delay rather than prevent gallstone recurrence after extracorporeal shock wave lithotripsy. J Hepatol 35:10-16
60. Festi D, Frabboni R, Bazzoli F et al (1990) Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology 99:1779-1785
61. Portincasa P, Di Ciaula A, Baldassarre G et al (1994) Gallbladder motor function in gallstone patients: sonographic and in vitro studies on the role of gallstones, smooth muscle function and gallbladder wall inflammation. J Hepatol 21:430-440
62. Pereira SP, Veysey MJ, Kennedy C et al (1997) Gallstone dissolution with oral bile acid therapy - Importance of pretreatment CT scanning and reasons for nonresponse. Dig Dis Sci 42:1775-1782
63. Pereira SP, Hussaini SH, Kennedy C et al (1995) Gallbladder stone recurrence after medical treatment. Do gallstones recur true to type? Dig Dis Sci 40:2568-2575
64. Sherlock S, Dooley J (2002) Diseases of the liver and biliary system. Oxford, Blackwell Science
65. Sackmann M, Eder H, Spengler U et al (1993) Gallbladder emptying is an important factor in fragment disappearance after shock wave lithotripsy. J Hepatol 17:62-66
66. Schiff M (1873) Il coleinato di soda nella cura dei calcoli biliari. L'Imparziale 13:97-98
67. Dabney WC (1876) The use of choleate of soda to prevent the formation of gallstones. Am J Med Sci 71:410
68. Rewbridge AG (1937) The disappearance of gallstone shadows following the prolonged admnistration of bile acids. Surgery 1:395-400
69. Danzinger RG, Hofmann AF, Schoenfield LJ (1972) Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med 286:1-8
70. Makino I, Shinozaki K, Yoshino K et al (1975) [Dissolution of cholesterol gallstones by longterm administration of ursodeoxycholic acid]. Nippon Shokakibyo Gakkai Zasshi 72:690-702
71. Mouret P (1990) [Celioscopic surgery. Evolution or revolution?] Chirurgie 116:829-832
72. van de Heijning BJM, van de Meeberg P, Portincasa P et al (1999) Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones. Dig Dis Sci 44:190-196
73. Guarino MP, Cong P, Cicala M et al (2007) Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones. Gut 56:815-820
74. van Erpecum KJ, Portincasa P, Stolk MFJ et al (1994) Effects of bile salt and phospholipid hydrophobicity on lithogenicity of human gallbladder bile. Eur J Clin Invest 24:744-750
75. van Erpecum KJ, Portincasa P, Gadellaa M et al (1996) Effects of bile salt hydrophobicity on nucleation behaviour of cholesterol crystals in model bile. Eur J Clin Invest 26:602-608
76. Portincasa P, van Erpecum KJ, Jansen A et al (1996) Behavior of various cholesterol crystals in bile from gallstone patients. Hepatology 23:738-748
77. Moschetta A, van Berge-Henegouwen GP, Portincasa P et al (2001) Cholesterol crystallization in model biles. Effects of bile salt and phospholipid species composition. J Lipid Res 42:1273-1281
78. Venneman NG, Huisman SJ, Moschetta A et al (2002) Effects of hydrophobic and hydrophilic bile salt mixtures on cholesterol crystallization in model biles. Biochim Biophys Acta 1583:221-228
79. Venneman NG, van Kammen M, Renooij W et al (2005) Effects of hydrophobic and hydrophilic bile salts on gallstone growth and dissolution in model biles. Biochim Biophys Acta 3:209-219
80. Sugerman HJ, Brewer WH, Shiffman ML et al (1995) A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 169:91-96
81. Paumgartner G (1996) Therapeutic options and choice of appropriate treatment. In: Bile acids - Cholestasis - Gallstones. Advances in basic and clinical bile acid research. Dordrecht, Kluwer Academic Publishers, pp 205-210
82. Sackmann M, Ippisch E, Sauerbruch T et al (1990) Early gallstone recurrence rate after successful shock-wave therapy. Gastroenterology 98:392-396
83. Villanova N, Bazzoli F, Taroni F et al (1989) Gallstone recurrence after successful oral bile acid treatment: a 12 year follow-up study and evaluation of long term postdissolution treatment. Gastroenterology 97:726-731
84. Petroni ML, Jazrawi RP, Pazzi P et al (2000) Risk factors for the development of gallstone recurrence following medical dissolution. The British-Italian Gallstone Study Group. Eur J Gastroenterol Hepatol 12:695-700
85. Wang DQH, Carey MC (1996) Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physicalchemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing system. J Lipid Res 37:606-630